THC
Tenet Healthcare Corporation
NYSE: THC · HEALTHCARE · MEDICAL CARE FACILITIES
$191.68
+0.43% today
Updated 2026-06-05
Market cap
$15.04B
P/E ratio
9.08
P/S ratio
0.70x
EPS (TTM)
$19.23
Dividend yield
—
52W range
$147 – $247
Volume
1.4M
WallStSmart proprietary scores
66
out of 100
Grade: B
Buy
Investment rating
6.0
Growth
B4.5
Quality
C7.0
Profitability
B+5.7
Valuation
C+4/9
Piotroski F-Score
Moderate
1.7
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →199 stocks currently score above 75
Price targets
Analyst target
$243.62
+27.10%
12-Month target
$200.53
+4.62%
Intrinsic (DCF)
—
Margin of safety
—
6 Strong Buy14 Buy2 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ ROE 35.38% — strong efficiency
+ Free cash flow $1.46B — positive
Risks
- Altman Z 1.73 — distress zone
- Debt/equity 2.74x — high leverage
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $19.17B | $20.55B | $20.66B | $21.31B | $21.45B |
| Net income | $411.00M | $611.00M | $3.20B | $1.41B | $702.00M |
| EPS | — | — | — | — | $19.23 |
| Free cash flow | $321.00M | $1.62B | $1.12B | $2.53B | $1.46B |
| Profit margin | 2.14% | 2.97% | 15.49% | 6.60% | 7.94% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-28 | KERREY, J ROBERT | Sale | 1,969 | $173.12 |
| 2026-05-28 | KERREY, J ROBERT | Sale | 1,690 | $173.97 |
| 2026-05-28 | KERREY, J ROBERT | Sale | 905 | $176.89 |
Peer comparison
Smart narrative
Tenet Healthcare Corporation trades at $191.68. representing a P/E of 9.08x trailing earnings. Our Smart Value Score of 66/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 1.73, it sits in the distress. TTM revenue stands at $21.45B. with profit margins at 7.94%.
Frequently asked questions
What is Tenet Healthcare Corporation's stock price?
Tenet Healthcare Corporation (THC) trades at $191.68, on a P/E of 9.1x and a P/S of 0.7x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Tenet Healthcare Corporation overvalued?
Tenet Healthcare Corporation carries a Smart Value Score of 66/100 (Grade B), which we rate Buy. That score blends growth, quality, and valuation into one read.
What is the price target of Tenet Healthcare Corporation (THC)?
The 12-month analyst consensus target is $243.62, about 27.1% above the current $191.68. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Tenet Healthcare Corporation's revenue?
Tenet Healthcare Corporation's trailing twelve-month revenue is $21.45B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Tenet Healthcare Corporation's Altman Z-Score is 1.73, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.70x
ROE35.38%
Beta1.28
50D MA$184.09
200D MA$198.90
Shares out0.09B
Float0.09B
Short ratio—
Avg volume1.4M
Performance
1 week+0.00%
1 month-8.96%
3 months-19.11%
YTD-18.45%
1 year—
3 years—
5 years—